These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 29229491)

  • 21. The challenges in developing a rational cannabis policy.
    Hall W; Lynskey M
    Curr Opin Psychiatry; 2009 May; 22(3):258-62. PubMed ID: 19293714
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HIV, injecting drug use and harm reduction: a public health response.
    Ball AL
    Addiction; 2007 May; 102(5):684-90. PubMed ID: 17506148
    [TBL] [Abstract][Full Text] [Related]  

  • 23. UNGASS 2016: Insights from Europe on the development of global cannabis policy and the need for reform of the global drug policy regime.
    Chatwin C
    Int J Drug Policy; 2017 Nov; 49():80-85. PubMed ID: 26795703
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Qualitative research in Spanish cannabis social clubs: "The moment you enter the door, you are minimising the risks".
    Belackova V; Tomkova A; Zabransky T
    Int J Drug Policy; 2016 Aug; 34():49-57. PubMed ID: 27461986
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drug policy and Collective Health: necessary dialogues.
    Gomes-Medeiros D; Faria PH; Campos GWS; Tófoli LF
    Cad Saude Publica; 2019 Jul; 35(7):e00242618. PubMed ID: 31365702
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Drug addiction: between classification and social and health policies].
    Amato L; Davoli M
    Recenti Prog Med; 2014 Mar; 105(3):91-2. PubMed ID: 24675448
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Harm Reduction Policies Where Drugs Constitute a Security Issue.
    Narvaez-Chicaiza MA
    Health Care Anal; 2020 Dec; 28(4):382-390. PubMed ID: 33136222
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transnational social movement theory and the waning war on drugs: Case studies from UNGASS 2016.
    Mostyn B; Gibbon H
    Int J Drug Policy; 2018 Jan; 51():148-155. PubMed ID: 29273560
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cannabis policy and the uptake of treatment for cannabis-related problems.
    Adam C; Raschzok A
    Drug Alcohol Rev; 2017 Mar; 36(2):171-177. PubMed ID: 27004985
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drug Policy and the Public Good: a summary of the book.
    Drugs and Public Policy Group
    Addiction; 2010 Jul; 105(7):1137-45. PubMed ID: 20642498
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Beyond deficit and harm reduction: Incorporating the spectrum of wellness as an interpretive framework for cannabis consumption.
    Subritzky T
    Int J Drug Policy; 2018 Oct; 60():18-23. PubMed ID: 30086481
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessing the harms of cannabis cultivation in Belgium.
    Paoli L; Decorte T; Kersten L
    Int J Drug Policy; 2015 Mar; 26(3):277-89. PubMed ID: 25599596
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Harm reduction in name, but not substance: a comparative analysis of current Canadian provincial and territorial policy frameworks.
    Hyshka E; Anderson-Baron J; Karekezi K; Belle-Isle L; Elliott R; Pauly B; Strike C; Asbridge M; Dell C; McBride K; Hathaway A; Wild TC
    Harm Reduct J; 2017 Jul; 14(1):50. PubMed ID: 28747183
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A national public health programme on gambling policy development in New Zealand: insights from a process evaluation.
    Kolandai-Matchett K; Landon J; Bellringer M; Abbott M
    Harm Reduct J; 2018 Mar; 15(1):11. PubMed ID: 29510708
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Civil society-a leader in HIV prevention and tobacco control.
    Malinowska-Sempruch K; Bonnell R; Hoover J
    Drug Alcohol Rev; 2006 Nov; 25(6):625-32. PubMed ID: 17132578
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cannabis policy in Australia and New Zealand.
    Abel S
    Drug Alcohol Rev; 1997 Dec; 16(4):421-8. PubMed ID: 16203457
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drugs, communities, and "harm reduction" in Germany: the new relevance of "public health" principles in local responses.
    Fischer B
    J Public Health Policy; 1995; 16(4):389-411. PubMed ID: 8907762
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preferences for policy options for cannabis in an Australian general population: A discrete choice experiment.
    Shanahan M; Gerard K; Ritter A
    Int J Drug Policy; 2014 Jul; 25(4):682-90. PubMed ID: 24746863
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Overview of "home" cultivation policies and the case for community-based cannabis supply.
    Belackova V; Roubalova Stefunkova M; van de Ven K
    Int J Drug Policy; 2019 Sep; 71():36-46. PubMed ID: 31200326
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Global patterns of domestic cannabis cultivation: sample characteristics and patterns of growing across eleven countries.
    Potter GR; Barratt MJ; Malm A; Bouchard M; Blok T; Christensen AS; Decorte T; Frank VA; Hakkarainen P; Klein A; Lenton S; Perälä J; Werse B; Wouters M
    Int J Drug Policy; 2015 Mar; 26(3):226-37. PubMed ID: 25582281
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.